Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
about
Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human DiseaseGenetic instability in the tumor microenvironment: a new look at an old neighborCaught in the cross fire: p53 in inflammation.Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myelomap53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum ConceptInfluence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated ProteinsCombining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapyPotential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.Folate deficiency as predisposing factor for childhood leukaemia: a review of the literature.p53 Family and Cellular Stress Responses in Cancer.A naturally occurring 4-bp deletion in the intron 4 of p53 creates a spectrum of novel p53 isoforms with anti-apoptosis function.Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ∆133p53α mimic.Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous nicheGenome-wide association study reveals novel loci for litter size and its variability in a Large White pig population.Analysis of the correlation between P53 and Cox-2 expression and prognosis in esophageal cancer.Cross-species Conservation of context-specific networks.Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records.Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic TargetsAberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerDamage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.Alternative splicing of DNA damage response genes and gastrointestinal cancers.Correlation of TP53 Overexpression and Clinical Parameters with Five-Year Survival in Oral Squamous Cell Carcinoma PatientsNovel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.Tumor suppressive function of microRNA-192 in acute lymphoblastic leukemia.Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 statusΔ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.The Paradox of p53: What, How, and Why?Genomics of Esophageal Cancer and Biomarkers for Early Detection.ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.Development of a novel immunoassay to detect interactions with the transactivation domain of p53: application to screening of new drugsp53 isoforms change p53 paradigm.Effects of ADMA on gene expression and metabolism in serum-starved LoVo cellsImmunohistochemical detection of the receptor activator of nuclear factor Kappa B ligand and c-fos in giant cell granuloma.A new mild hyperthermia device to treat vascular involvement in cancer surgery.p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration.Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ.Mdm4: don't judge an isoform by its mRNA levels!
P2860
Q26767093-CDE2D468-0685-4226-89D6-380BC4C91AE0Q26801374-01E2C65F-9CBD-44A6-966A-72E2A3712197Q27692076-B05DDB4D-31B1-41C7-9B20-082613461746Q28074490-4915C340-1299-4901-BF3D-278817CF6015Q28079390-5888CEB5-CA1E-45BA-B0A6-02A8BB0B2994Q28552225-74220617-7B6F-4E15-85A6-C0C3D5BCCB2CQ33633277-47BDD456-D645-43BF-BFD7-6E03E0AB2717Q33753279-8041185F-FBDF-47CC-BCDE-0A6B17CD6D8FQ33756188-C141F838-58F7-45D1-A3D5-7D71D5325E59Q34377287-F19A0D3B-42FF-455D-8750-8631136CB783Q35098047-A2F9440E-972E-4ECE-A52B-935D68CC9353Q35229048-BAAB0C44-6EA3-4CF3-A82C-C37CF4292E5DQ35553620-C3DB16EC-75DD-4000-A981-DF6F1B6F3B04Q35717532-EAF5ED8E-3DAC-4597-8ACD-2E8C4F7D44D1Q35864923-70059B74-3BC3-4B7E-BB8B-23F9D00DCB89Q36085628-2E4FFE64-8953-4353-B157-62811C81B26AQ36105392-0E0F29CE-FEF8-40D7-A960-7E65DB9C0326Q36216271-A8BB82F0-18C8-4A1E-967C-E3D3A838975EQ36658489-5DEB6256-DF5C-4122-B128-296927530980Q37306546-A3FF8547-FA6A-45CB-9A33-0E6C0DB863B3Q37418067-1002B6FE-D0A0-4F9F-8220-32A5C0CF813DQ37629073-175AAE9F-D1C8-48E2-842F-C7B850D385A3Q38291477-E27B7BFE-70DE-4B9E-ADE0-38FB0FD0346FQ38601338-696E8FED-1343-41A3-A163-317C0D958FEBQ38620814-C57E5F18-68D2-4814-B384-0A41E124D0BDQ38704088-103FD42C-DF92-4693-9A34-565E15561DA2Q38751430-4CACC5E7-80A1-42A5-8762-AA1F74907E49Q38864733-C138DC88-1FB4-43A7-BB12-24B1F15D38CFQ38896065-ED0B8FC2-2BA1-4769-A418-24BCAA6F63F8Q38940530-0FD9B3CD-91DB-40C1-AC29-CF6E4924BD17Q39141159-965E43F8-1A9E-4A39-83BA-39354ED9D56DQ39341353-5FFA3ED3-1CB1-4D62-B198-1A06B7EB8AE5Q39608263-02300A4E-FBA4-4CF2-B97E-65172C8E9572Q39679548-27AEF769-9E9B-4DD4-ABD0-B3831ED30C11Q39765027-7966E8DE-413E-40AB-B191-78271B84E173Q41188020-A58AD9AD-F618-4274-A907-76AC76A95A20Q41198521-6AD9CE9C-26E6-4EC7-B320-6134C30A2C90Q41517672-58A3AEE0-9485-4537-960A-30FD24C55C06Q42787889-34A69D11-4D30-4E7C-B54D-E636D48CE2BBQ43184273-2BA79BB0-1B0F-46F9-B920-E52362ED5129
P2860
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@ast
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@en
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@nl
type
label
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@ast
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@en
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@nl
prefLabel
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@ast
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@en
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@nl
P2860
P3181
P356
P1476
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
@en
P2093
Marie P Khoury
Sylvanie Surget
P2860
P3181
P356
10.2147/OTT.S53876
P407
P577
2013-12-19T00:00:00Z